Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 478

Results For "NAL"

7121 News Found

2.5 lakh+ people voluntarily donated blood under the Raktdaan Amrit Mahotsav
News | October 03, 2022

2.5 lakh+ people voluntarily donated blood under the Raktdaan Amrit Mahotsav

Mandaviya felicitated voluntary blood donors and states/UTs that have done exemplary work


SPARSH Hospitals, MGM Healthcare, Chennai to offer heart failure management program in Bengaluru
Healthcare | October 03, 2022

SPARSH Hospitals, MGM Healthcare, Chennai to offer heart failure management program in Bengaluru

This new initiative will cater to the increasing number of patients in Karnataka in need of heart and lung Failure management and transplant


Indian medical devices industry to grow at 28% annually to reach US$ 50 bn by 2030: Health Minister
Policy | October 01, 2022

Indian medical devices industry to grow at 28% annually to reach US$ 50 bn by 2030: Health Minister

Department and Industry Associations to organize 3 days National Level Expo on Indian Medical Devices Sector at Pragati Maidan, New Delhi between 9-11 Dec 2022, first of its kind expo in India


Dr VK Paul delivers lecture at NITI Aayog’s First India Development Strategies Lecture Series
News | October 01, 2022

Dr VK Paul delivers lecture at NITI Aayog’s First India Development Strategies Lecture Series

Ours is a story of India’s resilient public health system and of everyone working together as team India to battle the pandemic


Japan homegrown COVID-19 mRNA vaccine needs superior safety and efficacy data for success, says GlobalData
News | October 01, 2022

Japan homegrown COVID-19 mRNA vaccine needs superior safety and efficacy data for success, says GlobalData

The booster vaccination trial is still ongoing and further data will provide more information around safety and efficacy.


Lupin receives US FDA approval for Mirabegron Extended-Release tablets
Drug Approval | September 30, 2022

Lupin receives US FDA approval for Mirabegron Extended-Release tablets

Mirabegron Extended-Release Tablets, 25 mg and 50 mg, had estimated annual sales of US $2.4 billion in US


Lupin launches Sildenafil for Oral Suspension in US
Drug Approval | September 30, 2022

Lupin launches Sildenafil for Oral Suspension in US

Sildenafil for Oral Suspension (RLD Revatio) had estimated annual sales of US $64 million in the US


Supriya Lifescience appoints Rajeev Kumar Jain as CEO
People | September 28, 2022

Supriya Lifescience appoints Rajeev Kumar Jain as CEO

He is a seasoned professional having worked in reputed corporates in API business with over 35+ years of experience covering manufacturing, general management, and business


South Korea nextgen sequencing tests market to grow at 4% CAGR during 2022-2030: GlobalData
Clinical Trials | September 28, 2022

South Korea nextgen sequencing tests market to grow at 4% CAGR during 2022-2030: GlobalData

There is also a growing interest in whole generation sequencing (WGS)